Neuronetics prices $30M share offering to address going concern risk
Neuronetics (STIM) is pricing 18.75M shares at $1.60, raising about $30M gross. Proceeds may help repay debt and ease going concern risk, per the company.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, citing a GlobeNewswire release, Neuronetics (STIM) has priced 18.75M shares at $1.60 each. Gross proceeds before expenses are about $30M, and the closing is expected around November 12, 2026.
Underwriters have a 30-day option to buy up to 2.8125M additional shares, which could raise both proceeds and dilution. Part of the money is intended for debt repayment and general corporate purposes.
why it matters
The deal is tied to a loan amendment: a prepayment of at least $15M is a condition for reduced revenue covenants, which the company says would resolve going concern risk. That outcome is conditional, and the conditions must be met by November 30, 2026. For investors, the story is about financing and balance-sheet pressure rather than improved operating results, and share dilution is a key factor.
tags
instruments
sources
- Neuronetics (STIM) Prices $30M Offering; Proceeds May Address Going Concern Risk — TradingView, 11 November 2026 at 03:39 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗